Drug profile · INN
propoxyphene napsylate
DARVON-N
propoxyphene napsylate (DARVON-N) is a mu opioid receptor agonist. Associated with Dyne Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Drug details — propoxyphene napsylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 15
- Programs
- 0
- Data quality
- 0.89
Quick answer
propoxyphene napsylate (DARVON-N) is a mu opioid receptor agonist. Associated with Dyne Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor agonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 12168648
Opioid receptor modulators
granted -
US 11723762
LIDAR based 3-D imaging with far-field illumination overlap
granted -
US 11634396
Opioid receptor modulators
granted -
US 11634452
Compounds for treating neurodegenerative disorders
granted -
US 11129864
Method for obtaining a plant extract and associated compositions
granted -
US 10933086
Composition for preventing, alleviating, or treating arthritis or osteoporosis, containing neoagarooligosaccharide
granted -
US 9999647
Method for obtaining a plant extract and associated compositions
granted -
US 9279366
Steam powered engine
granted -
US 7811297
Actuable structures and methods of fabrication and use
granted -
US 7777027
Purified beta glucan composition
granted -
US 7550584
Methods of purifying beta glucans
granted -
US 7361476
Methionyl tRNA synthetase polynucleotides
granted -
US 7335499
tRNA synthetase
granted -
US 6989255
Methionyl tRNA synthetase polypeptides from Staphylococcus aureus
expired -
US 6162787
Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
expired
Frequently asked questions
What is propoxyphene napsylate?
propoxyphene napsylate (DARVON-N) is a mu opioid receptor agonist. Associated with Dyne Therapeutics. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for propoxyphene napsylate?
DARVON-N is a marketed brand name for propoxyphene napsylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of propoxyphene napsylate?
propoxyphene napsylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.